Literature DB >> 9831442

Changes in interferon-regulatory factor-1 mRNA levels after transient ischemia in rat brain.

W Paschen1, C Gissel, S Althausen, J Doutheil.   

Abstract

To evaluate whether the interferon system in the brain is activated by a severe form of metabolic stress, and to elucidate the possible mechanism underlying this activation, changes in the interferon regulatory factor-1 (irf-1) mRNA levels were evaluated after transient cerebral ischemia, and after exposure of primary neuronal cells to experimental conditions resulting in a depletion of ER calcium stores. Following 30 min ischemia and 2 h recovery, irf-1 mRNA levels rose significantly and stayed high for up to 24 h of recovery. Irf-1 mRNA levels were also significantly increased in neurons in vitro after exposing cells to conditions resulting in ER calcium store depletion with or without a parallel increase in cytoplasmic calcium activity. It is concluded that transient cerebral ischemia induces activation of the interferon system and that disturbances of ER calcium homeostasis may play a role in this process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9831442     DOI: 10.1097/00001756-199810050-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  3 in total

1.  UBE3A regulates the transcription of IRF, an antiviral immunity.

Authors:  Ryohei Furumai; Kota Tamada; Xiaoxi Liu; Toru Takumi
Journal:  Hum Mol Genet       Date:  2019-06-15       Impact factor: 6.150

2.  Tumor necrosis factor alpha induces a metalloprotease-disintegrin, ADAM8 (CD 156): implications for neuron-glia interactions during neurodegeneration.

Authors:  U Schlomann; S Rathke-Hartlieb; S Yamamoto; H Jockusch; J W Bartsch
Journal:  J Neurosci       Date:  2000-11-01       Impact factor: 6.167

3.  Axotomy-induced miR-21 promotes axon growth in adult dorsal root ganglion neurons.

Authors:  Iain T Strickland; Louise Richards; Fiona E Holmes; David Wynick; James B Uney; Liang-Fong Wong
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.